Press release
Lipid Nanoparticles Market to Reach USD 350.5M by 2029
Key players in the lipid nanoparticles market include Avanti Polar Lipids (Croda International plc (US), Merck KGaA (Germany), Evonik Industries AG (Germany), FUJIFILM Pharmaceuticals U.S.A., Inc. (US), Nippon Fine Chemical (Japan), Recipharm AB (Sweden)
The global lipid nanoparticles market [https://www.marketsandmarkets.com/Market-Reports/lipid-nanoparticles-market-70136984.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=lipidnanoparticlesmarket] is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a CAGR of 5.2%, while the LNP services market is projected to rise from USD 135.5 million in 2024 to USD 238.1 million by 2029 at a CAGR of 11.9%. Growth is driven by advancements in LNP-based pharmaceuticals, particularly in anti-cancer and mRNA therapies, though regulatory challenges and formulation issues pose potential constraints. Key opportunities include the demand for advanced drug delivery systems and scalable mRNA vaccines. The market's key players include Avanti Polar Lipids, Merck KGaA, and FUJIFILM Pharmaceuticals, with North America being the leading regional market. The sector is influenced by diverse product segments such as ionizable and PEGylated lipids, with applications spanning COVID-19 and cancer treatments.
Download PDF Brochure: [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=70136984&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=lipidnanoparticlesmarket]
Browse in-depth TOC on "Lipid Nanoparticles Market"
398 - Tables
53 - Figures
316 - Pages
Factors Influencing Market Trends
The expansion of the lipid nanoparticles market is driven by increasing research and development efforts to create lipid nanoparticle-based drugs. However, stringent regulatory requirements may impede growth.
Product Segment Insights
The market is segmented by product into ionizable lipids, PEGylated lipids, neutral lipids, phospholipids, kits & reagents, and other formulation materials, with ionizable lipids leading due to their crucial role in mRNA vaccines like Pfizer-BioNTech's BNT162b2 and Moderna's mRNA-1273.
LNP Type Breakdown
Segmented into solid lipid nanoparticles, nanostructured lipid carriers, and other types, the solid lipid nanoparticles segment holds the largest share, favored for vaccine production and as an alternative drug delivery carrier.
Molecule Type Distribution
The market is divided by molecule type into siRNA, mRNA, and other molecules. The mRNA segment dominates due to its effectiveness in vaccine production and the enhanced delivery capabilities of lipid nanoparticles.
Application Areas
Segmented into commercial and clinical applications, the commercial segment currently holds the largest market share due to its extensive use in vaccine production. The clinical applications segment, however, is expected to grow the fastest, driven by advancements in targeted drug delivery and personalized medicine.
End-User Analysis for Raw Materials
For raw materials, the market is divided into pharmaceutical & biotechnology companies, academic & research institutes, and CDMOs, with pharmaceutical & biotechnology companies holding the largest share due to their high use of lipid nanoparticles in drug development.
Service Type Analysis
The lipid nanoparticles services market, categorized into formulation development services, manufacturing services, and other services, sees the largest share in manufacturing services. This is driven by the high demand for raw materials and ongoing requirements from pharmaceutical and biotechnology companies.
End-User Analysis for Services
The services market is segmented by end users into pharmaceutical & biotechnology companies and academic & research institutes, with pharmaceutical & biotechnology companies leading due to their need for specialized manufacturing services and expertise.
Regional Market Overview
The lipid nanoparticles market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America held the largest share in 2023, benefiting from advanced healthcare infrastructure and significant R&D investments. However, the Asia Pacific region is anticipated to be the fastest-growing market during the forecast period, driven by increased healthcare expenditure, government initiatives, and favorable regulatory conditions.
Request Sample Pages: [https://www.marketsandmarkets.com/requestsampleNew.asp?id=70136984&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=lipidnanoparticlesmarket]
Growth Drivers and Challenges
The growth of the lipid nanoparticles market is driven by their increasing use in anti-cancer and RNA-based therapies. However, stringent regulatory requirements related to lipid nanoparticles may pose challenges to market expansion.
Market Consolidation
The lipid nanoparticles market is largely consolidated, with major players such as Avanti Polar Lipids (Croda International plc), Merck KGaA, NOF CORPORATION, and Nippon Fine Chemical holding 70-75% of the global market share.
Company Profiles
Avanti Polar Lipids (US): Established in 1967, Avanti specializes in high-purity lipids for biochemical and pharmaceutical research. The company offers a broad portfolio of lipid nanoparticles and custom synthesis services, heavily investing in R&D and collaborating with academic institutions to advance lipid formulations.
Merck KGaA (Germany): This healthcare and life sciences company provides a range of lipid nanoparticles products for research and clinical applications. Merck KGaA has strengthened its RNA production capabilities and recently acquired Exelead for approximately USD 780 million to enhance its CDMO services.
NOF CORPORATION (Japan): NOF CORPORATION is a prominent chemical manufacturer known for its lipid nanoparticle formulations. In April 2024, NOF collaborated with Phosphorex to provide lipid nanoparticles using their COATSOME Registered SA Series, which offers efficient nucleic acid delivery with minimal toxicity. NOF continues to innovate with high-purity lipid derivatives and liposome formulations for various drug applications.
For more information, [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=70136984&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=lipidnanoparticlesmarket]!
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lipid-nanoparticles-market-to-reach-usd-3505m-by-2029]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/lipid-nanoparticles-market-70136984.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lipid Nanoparticles Market to Reach USD 350.5M by 2029 here
News-ID: 3897264 • Views: …
More Releases from ABNewswire
RankPage Reports Surge in Companies Seeking AI-Driven SEO Solutions Across Malay …
Image: https://www.abnewswire.com/upload/2025/12/ce0998bc399df9d119f24fa37ec5ec6b.jpg
Businesses in Malaysia are experiencing rapid digital transformation. With more companies moving online, competition has grown significantly across all industries. Whether it's retail, finance, hospitality, or healthcare, every brand now fights for visibility on search engines. This is the point where SEO becomes a powerful tool.
By investing in search engine optimization, businesses are able to stay ahead of their competitors and attract high-quality traffic without relying heavily on paid…
New Guide Explains the First Meeting With a Jersey City Criminal Lawyer
The initial encounter with a Jersey City Criminal Defense Attorney [https://www.newjerseycriminallawfirm.com/jersey-city-criminal-lawyer/] can be very daunting especially when you are suspected or suspected of a crime. However, knowing what happens in this initial meeting can help you feel better prepared, confident and in control of your situation. This meeting is crucial. It will determine the nature of your defense plan and it will also make you know whether this lawyer is…
Automobile Allies - The Court Role of a California Lemon Law Attorney
Buying a new car should be a safe, easy, and trustworthy choice. However, take into account that the situation when a car keeps breaking down or visiting the garage more than driving on roads soon gives rise to sheer annoyance. A lot of people living in California don't realize at first that the Lemon Law which is in place to protectconsumers gives them the right to claim a defective vehicle…
Jimmy Gusky Heating & Air LLC Expands HVAC Services Washington DC with Enhanced …
Jimmy Gusky Heating & Air LLC expands emergency HVAC response capabilities in Washington DC with 24/7 service, advanced diagnostics, and comprehensive heating, cooling, and plumbing solutions for residential and commercial properties.
Washington DC homeowners and business owners now have access to enhanced emergency climate control solutions as Jimmy Gusky Heating & Air LLC [https://www.jimmygusky.com/] expands its rapid-response capabilities across the metropolitan area. The locally-owned company, providing hvac services washington dc for…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
